Work

Supplemental Table 1. from Use of Expansion Cohorts in Phase I Trials and Probability of Success in Phase II for 381 Anticancer Drugs

Year: 2023

Type: supplementary-materials

Abstract: Drugs Approved by the U.S. Food and Drug Administration by April 30, 2014, That Were Included in the Analysis

DOI: 10.1158/1078-0432.22467939.v1

Authors: Diogo D.G. Bugano, Kenneth Hess, Denis L.F. Jardim, Alona Zer, Funda Meric-Bernstam, Lillian L. Siu, Albiruni R.A. Razak, David S. Hong

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361967952

Cites:

Cited by:

Related to: 10